250,64 €
278,49 €
-10% with code: EXTRA
Renal Cell Carcinoma
Renal Cell Carcinoma
250,64
278,49 €
  • We will send in 10–14 business days.
Section I: Localized Disease1. Etiology of RCC: Incidence, Demographics, and Environmental FactorsBy Frédéric D. Birkhäuser, MD, Nils Kroeger, MD, and Allan J. Pantuck, MD MS FACS 2. Pathology of Renal Cell CarcinomaBy Ming Zhou, MD PhD, Huiying He 3. Familial Renal Cell CarinomaBy Simon P. Kim, MD, MPH, Bradley C. Leibovich, MD 4. Imaging of Renal Cell Carcinoma By Andrei S. Purysko, MD, Erick M. Remer MD, Brian R. Herts, MD 5. Prognostic Factors for Localized Renal Cell Carcinoma By Brian…
278.49
  • Publisher:
  • ISBN-10: 1493962655
  • ISBN-13: 9781493962655
  • Format: 17.8 x 25.4 x 2 cm, minkšti viršeliai
  • Language: English
  • SAVE -10% with code: EXTRA

Renal Cell Carcinoma (e-book) (used book) | bookbook.eu

Reviews

(4.00 Goodreads rating)

Description

Section I: Localized Disease

1. Etiology of RCC: Incidence, Demographics, and Environmental Factors

By Frédéric D. Birkhäuser, MD, Nils Kroeger, MD, and Allan J. Pantuck, MD MS FACS

2. Pathology of Renal Cell Carcinoma

By Ming Zhou, MD PhD, Huiying He

3. Familial Renal Cell Carinoma

By Simon P. Kim, MD, MPH, Bradley C. Leibovich, MD

4. Imaging of Renal Cell Carcinoma

By Andrei S. Purysko, MD, Erick M. Remer MD, Brian R. Herts, MD

5. Prognostic Factors for Localized Renal Cell Carcinoma

By Brian R. Lane, MD, PhD.

Section II: Management of Localized RCC

6. Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass BiopsyBy Matthew N. Simmons MD PhD, Steven C. Campbell MD PhD

7. Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations

By Paul Russo, MD FACS

8. Nephron-Sparing Surgery for Renal Cancer

By Alon Z. Weizer MD, MS, Jeffery S. Montgomery MD, MHSA, Khaled S. Hafez, MD

9. Thermal Ablation

By Surena F. Matin MD FACS, Kamran Ahrar MD

10. Active Surveillance of the Small Renal Mass

By Marc C. Smaldone, MD, Daniel Canter, MD, Alexander Kutikov, MD, Robert G. Uzzo, MD FACS

Section III: Locally Advanced Disease

11. Locally Advanced Renal Cell Carcinoma

By Stephen H. Culp, MD PhD, Christopher G. Wood, MD FACS

12. Neoadjuvant Targeted Therapy and Consolidative Surgery

By Sean P. Stroup MD. Ithaar H. Derweesh, MD

Section IV: Advanced Disease

13. Biology of RCC (VEGF, mTOR, immune aspects)

By Alexandra Arreola, W. Kimryn Rathmell, MD, PhD

14. Prognostic Factors in Advanced Renal Cell Carcinoma

By Michael M. Vickers MD, Daniel Y. C. Heng MD MPH

15. Integration of Surgery in Metastatic Renal Cancer

By Tom Powles, MBBS MRCP MD, Axel Bex, MD

16. Immunotherapy for Renal Cell Carcinoma

By Diwakar Davar, MD, Moon Fenton, MD, Leonard J Appleman, MD, PhD

17. Targeted Therapy: Vascular Endothelial Growth Factor (VEGF)

By Linda Cerbone MD, Cora N. Sternberg, MD

18. mTOR in Renal cell carcinoma

By Eric Jonasch, MD, Michel Choueiri, MD

19. Palliative and Supportive Care for Renal Cancer

By Armida Parala-Metz MD, Mellar Davis MD

EXTRA 10 % discount with code: EXTRA

250,64
278,49 €
We will send in 10–14 business days.

The promotion ends in 21d.21:00:43

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 2,78 Book Euros!?
  • Publisher:
  • ISBN-10: 1493962655
  • ISBN-13: 9781493962655
  • Format: 17.8 x 25.4 x 2 cm, minkšti viršeliai
  • Language: English English

Section I: Localized Disease

1. Etiology of RCC: Incidence, Demographics, and Environmental Factors

By Frédéric D. Birkhäuser, MD, Nils Kroeger, MD, and Allan J. Pantuck, MD MS FACS

2. Pathology of Renal Cell Carcinoma

By Ming Zhou, MD PhD, Huiying He

3. Familial Renal Cell Carinoma

By Simon P. Kim, MD, MPH, Bradley C. Leibovich, MD

4. Imaging of Renal Cell Carcinoma

By Andrei S. Purysko, MD, Erick M. Remer MD, Brian R. Herts, MD

5. Prognostic Factors for Localized Renal Cell Carcinoma

By Brian R. Lane, MD, PhD.

Section II: Management of Localized RCC

6. Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass BiopsyBy Matthew N. Simmons MD PhD, Steven C. Campbell MD PhD

7. Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations

By Paul Russo, MD FACS

8. Nephron-Sparing Surgery for Renal Cancer

By Alon Z. Weizer MD, MS, Jeffery S. Montgomery MD, MHSA, Khaled S. Hafez, MD

9. Thermal Ablation

By Surena F. Matin MD FACS, Kamran Ahrar MD

10. Active Surveillance of the Small Renal Mass

By Marc C. Smaldone, MD, Daniel Canter, MD, Alexander Kutikov, MD, Robert G. Uzzo, MD FACS

Section III: Locally Advanced Disease

11. Locally Advanced Renal Cell Carcinoma

By Stephen H. Culp, MD PhD, Christopher G. Wood, MD FACS

12. Neoadjuvant Targeted Therapy and Consolidative Surgery

By Sean P. Stroup MD. Ithaar H. Derweesh, MD

Section IV: Advanced Disease

13. Biology of RCC (VEGF, mTOR, immune aspects)

By Alexandra Arreola, W. Kimryn Rathmell, MD, PhD

14. Prognostic Factors in Advanced Renal Cell Carcinoma

By Michael M. Vickers MD, Daniel Y. C. Heng MD MPH

15. Integration of Surgery in Metastatic Renal Cancer

By Tom Powles, MBBS MRCP MD, Axel Bex, MD

16. Immunotherapy for Renal Cell Carcinoma

By Diwakar Davar, MD, Moon Fenton, MD, Leonard J Appleman, MD, PhD

17. Targeted Therapy: Vascular Endothelial Growth Factor (VEGF)

By Linda Cerbone MD, Cora N. Sternberg, MD

18. mTOR in Renal cell carcinoma

By Eric Jonasch, MD, Michel Choueiri, MD

19. Palliative and Supportive Care for Renal Cancer

By Armida Parala-Metz MD, Mellar Davis MD

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)